These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 30334447

  • 1. CtBP2 promotes proliferation and reduces drug sensitivity in non-small cell lung cancer via the Wnt/β-catenin pathway.
    Wang DP, Gu LL, Xue Q, Chen H, Mao GX.
    Neoplasma; 2018 Nov 15; 65(6):888-897. PubMed ID: 30334447
    [Abstract] [Full Text] [Related]

  • 2. TAB3 overexpression promotes cell proliferation in non-small cell lung cancer and mediates chemoresistance to CDDP in A549 cells via the NF-κB pathway.
    Chen J, Gu J, Feng J, Liu Y, Xue Q, Ni T, Wang Z, Jia L, Mao G, Ji L.
    Tumour Biol; 2016 Mar 15; 37(3):3851-61. PubMed ID: 26476534
    [Abstract] [Full Text] [Related]

  • 3. Interferon Consensus Sequence-Binding Protein 8, a Tumor Suppressor, Suppresses Tumor Growth and Invasion of Non-Small Cell Lung Cancer by Interacting with the Wnt/β-Catenin Pathway.
    Ye L, Xiang T, Zhu J, Li D, Shao Q, Peng W, Tang J, Li L, Ren G.
    Cell Physiol Biochem; 2018 Mar 15; 51(2):961-978. PubMed ID: 30466106
    [Abstract] [Full Text] [Related]

  • 4. C-terminal binding protein-2 promotes cell proliferation and migration in breast cancer via suppression of p16INK4A.
    Yang X, Sun Y, Li H, Shao Y, Zhao D, Yu W, Fu J.
    Oncotarget; 2017 Apr 18; 8(16):26154-26168. PubMed ID: 28412731
    [Abstract] [Full Text] [Related]

  • 5. Downregulation of BarH-like homeobox 2 promotes cell proliferation, migration and aerobic glycolysis through Wnt/β-catenin signaling, and predicts a poor prognosis in non-small cell lung carcinoma.
    Chen H, Zhang M, Zhang W, Li Y, Zhu J, Zhang X, Zhao L, Zhu S, Chen B.
    Thorac Cancer; 2018 Mar 18; 9(3):390-399. PubMed ID: 29341468
    [Abstract] [Full Text] [Related]

  • 6. miRNA-125b regulates apoptosis of human non-small cell lung cancer via the PI3K/Akt/GSK3β signaling pathway.
    Wang Y, Zhao M, Liu J, Sun Z, Ni J, Liu H.
    Oncol Rep; 2017 Sep 18; 38(3):1715-1723. PubMed ID: 28713974
    [Abstract] [Full Text] [Related]

  • 7. High Kpnβ1 expression promotes non-small cell lung cancer proliferation and chemoresistance via the PI3-kinase/AKT pathway.
    Wang H, Wang D, Li C, Zhang X, Zhou X, Huang J.
    Tissue Cell; 2018 Apr 18; 51():39-48. PubMed ID: 29622086
    [Abstract] [Full Text] [Related]

  • 8. Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway.
    Cui Y, Zhang F, Zhu C, Geng L, Tian T, Liu H.
    Oncotarget; 2017 Mar 14; 8(11):17785-17794. PubMed ID: 28147312
    [Abstract] [Full Text] [Related]

  • 9. EPB41 suppresses the Wnt/β-catenin signaling in non-small cell lung cancer by sponging ALDOC.
    Yuan J, Xing H, Li Y, Song Y, Zhang N, Xie M, Liu J, Xu Y, Shen Y, Wang B, Zhang L, Yang M.
    Cancer Lett; 2021 Feb 28; 499():255-264. PubMed ID: 33242559
    [Abstract] [Full Text] [Related]

  • 10. Wnt signaling pathway in non-small cell lung cancer.
    Stewart DJ.
    J Natl Cancer Inst; 2014 Jan 28; 106(1):djt356. PubMed ID: 24309006
    [Abstract] [Full Text] [Related]

  • 11. Overexpression of HIF-2α-Dependent NEAT1 Promotes the Progression of Non-Small Cell Lung Cancer through miR-101-3p/SOX9/Wnt/β-Catenin Signal Pathway.
    Kong X, Zhao Y, Li X, Tao Z, Hou M, Ma H.
    Cell Physiol Biochem; 2019 Jan 28; 52(3):368-381. PubMed ID: 30845377
    [Abstract] [Full Text] [Related]

  • 12. Silence of fibronectin 1 increases cisplatin sensitivity of non-small cell lung cancer cell line.
    Gao W, Liu Y, Qin R, Liu D, Feng Q.
    Biochem Biophys Res Commun; 2016 Jul 15; 476(1):35-41. PubMed ID: 27207836
    [Abstract] [Full Text] [Related]

  • 13. Nemo-like kinase (NLK) inhibits the progression of NSCLC via negatively modulating WNT signaling pathway.
    Lv L, Wan C, Chen B, Li M, Liu Y, Ni T, Yang Y, Liu Y, Cong X, Mao G, Xue Q.
    J Cell Biochem; 2014 Jan 15; 115(1):81-92. PubMed ID: 23904219
    [Abstract] [Full Text] [Related]

  • 14. NEAT1 contributes to the CSC-like traits of A549/CDDP cells via activating Wnt signaling pathway.
    Jiang P, Xu H, Xu C, Chen A, Chen L, Zhou M, Haq IU, Wu X, Mariyam Z, Feng Q.
    Chem Biol Interact; 2018 Dec 25; 296():154-161. PubMed ID: 30291867
    [Abstract] [Full Text] [Related]

  • 15. HES5 promotes cellular proliferation of non-small cell lung cancer through STAT3 signaling.
    Gu S, Zhang R, Gu J, Li X, Lv L, Jiang J, Xu Z, Wang S, Shi C, Wang DP, Wu C.
    Oncol Rep; 2017 Jan 25; 37(1):474-482. PubMed ID: 27878283
    [Abstract] [Full Text] [Related]

  • 16. BCL9 promotes epithelial mesenchymal transition and invasion in cisplatin resistant NSCLC cells via β-catenin pathway.
    Zhang Y, Zhang Q, Chen H, Wang C.
    Life Sci; 2018 Sep 01; 208():284-294. PubMed ID: 30009824
    [Abstract] [Full Text] [Related]

  • 17. FOXP3 promotes tumor growth and metastasis by activating Wnt/β-catenin signaling pathway and EMT in non-small cell lung cancer.
    Yang S, Liu Y, Li MY, Ng CSH, Yang SL, Wang S, Zou C, Dong Y, Du J, Long X, Liu LZ, Wan IYP, Mok T, Underwood MJ, Chen GG.
    Mol Cancer; 2017 Jul 17; 16(1):124. PubMed ID: 28716029
    [Abstract] [Full Text] [Related]

  • 18. C-terminal binding protein‑2 mediates cisplatin chemoresistance in esophageal cancer cells via the inhibition of apoptosis.
    Shi H, Mao Y, Ju Q, Wu Y, Bai W, Wang P, Zhang Y, Jiang M.
    Int J Oncol; 2018 Jul 17; 53(1):167-176. PubMed ID: 29658564
    [Abstract] [Full Text] [Related]

  • 19. Downregulation of miR-3127-5p promotes epithelial-mesenchymal transition via FZD4 regulation of Wnt/β-catenin signaling in non-small-cell lung cancer.
    Yang Y, Sun Y, Wu Y, Tang D, Ding X, Xu W, Su B, Gao W.
    Mol Carcinog; 2018 Jul 17; 57(7):842-853. PubMed ID: 29566281
    [Abstract] [Full Text] [Related]

  • 20. Downregulation of Meg3 enhances cisplatin resistance of lung cancer cells through activation of the WNT/β-catenin signaling pathway.
    Xia Y, He Z, Liu B, Wang P, Chen Y.
    Mol Med Rep; 2015 Sep 17; 12(3):4530-4537. PubMed ID: 26059239
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.